Polyphenon E (green tea extract)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Polyphenon E (green tea extract), covering 2010-01-20 to 2020-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer [Phase 2]